Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ENT Devices: Large Markets, Minimally Invasive Procedures Fuel Innovation

This article was originally published in Start Up

Executive Summary

For innovators in the medical device industry, the otolaryngology or ENT (ear, nose, and throat) specialty offers just about everything that investors look for these days. Profiles of Aerin Medical, Spirox, Fiagon AG Medical, and ENTvantage Diagnostics.

You may also be interested in...



Newly Public Medtechs Gain In Share Price, Market Cap

The device IPO class of 2014 gained on share price, with several outperforming by more than 100%, and market caps for larger companies have grown at a rapid pace.

Spirox Inc.

Faced with the large unmet clinical need of people with chronic nasal obstruction, an ENT physician formed Spirox to develop a non-surgical implant to restore the nasal valve. The ultimate goal is to develop a 15-minute procedure that ENTs can perform in their office to help patients breathe better.

ENTvantage Diagnostics Inc.

Sinusitis is one malady that is prone to antibiotic overuse - antibiotics are prescribed for some 50% of patients, partly because busy physicians don’t feel they have the time to explain to them why an antibiotic is not appropriate. ENTvantage Diagnostics Inc. is developing a point-of-care diagnostic to quickly determine whether patients have bacterial or viral sinusitis.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT037980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel